![Kitty Yale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Kitty Yale formerly worked at Gilead Sciences, Inc., as Vice President-Clinical Operations from 2001 to 2018, Roche Global Development, as Senior Clinical Research & Operations, and Akero Therapeutics, Inc., as Chief Development Officer from 2018 to 2025.
Ms. Yale received her undergraduate degree from Glasgow Caledonian University.
Eerdere bekende functies van Kitty Yale
| Bedrijven | Functie | Einde |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Corporate Officer/Principal | 09-12-2025 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-10-2018 |
Roche Global Development | Corporate Officer/Principal | - |
Opleiding van Kitty Yale
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Glasgow Caledonian University
 Glasgow Caledonian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Global Development | |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
